{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:02:58Z","timestamp":1793656978612,"version":"4.5.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atrial fibrillation (AF) is a leading, modifiable risk factor for ischaemic stroke, with 20\u201330% of stroke patients harbouring underlying AF. Management of AF, however, differs substantially depending on clinical context. In ischaemic stroke patients with pre-known AF, direct oral anticoagulants (DOACs) are the cornerstone of secondary prevention, with initiation timing guided by infarct severity following a risk-adapted approach. In patients with no history of AF, prolonged cardiac rhythm monitoring after stroke or transient ischaemic attack improves AF detection rates. However, it remains uncertain whether this translates into a reduced risk of recurrent stroke, with randomised trials such as Find-AF 2 ongoing. Subclinical AF, detected via implantable devices, is associated with an increased stroke risk correlating with arrhythmia burden; recent trials (ARTESiA, NOAH-AFNET 6) suggest that anticoagulation may reduce ischaemic stroke risk in this population, but at the cost of increased bleeding, necessitating individualised decision-making. Particularly challenging are anticoagulation decisions with concomitant cerebral amyloid angiopathy or prior intracerebral haemorrhage (ICH) due to competing risks of thromboembolism and haemorrhage. Recent meta-analyses indicate that resuming DOACs after ICH reduces ischaemic events but significantly raises the risk of recurrent haemorrhage, without clear improvement in net clinical benefit. New treatment options, such as left atrial appendage closure, carotid artery filter systems, factor XIa inhibitors or rhythm control, must demonstrate in adequately powered randomised controlled trials that they can optimise treatment outcomes in this complex and growing patient group. This article summarises some common interdisciplinary neurological and cardiological questions and discusses the most recent evidence on AF-related stroke prevention across various patient groups, highlighting the importance of individualised, multidisciplinary, and imaging-informed decision-making.<\/jats:p>","DOI":"10.1186\/s42466-026-00538-9","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:12:57Z","timestamp":1792419177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Atrial fibrillation in stroke patients: facts, numbers and current challenges"],"prefix":"10.1186","volume":"8","author":[{"given":"Katrin","family":"Wasser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Bochert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna Rosemarie","family":"Leyhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Gr\u00f6schel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Gr\u00f6schel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Wachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"538_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/joim.12114","volume":"274","author":"L Friberg","year":"2013","unstructured":"Friberg, L., & Bergfeldt, L. (2013). Atrial fibrillation prevalence revisited. Journal Of Internal Medicine, 274, 461\u2013468. https:\/\/doi.org\/10.1111\/joim.12114","journal-title":"Journal Of Internal Medicine"},{"key":"538_CR2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H-C., Heidbuchel, H., Hendriks, J., et al. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal, 37, 2893\u20132962. https:\/\/doi.org\/10.1093\/eurheartj\/ehw210","journal-title":"European Heart Journal"},{"key":"538_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ana.25917","volume":"89","author":"TR Meinel","year":"2021","unstructured":"Meinel, T. R., Branca, M., de Marchis, G. M., Nedeltchev, K., Kahles, T., Bonati, L., Arnold, M., Heldner, M. R., Jung, S., Carrera, E., et al. (2021). Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation. Annals Of Neurology, 89, 42\u201353. https:\/\/doi.org\/10.1002\/ana.25917","journal-title":"Annals Of Neurology"},{"key":"538_CR4","doi-asserted-by":"publisher","unstructured":"Sposato, L. A., Cameron, A. C., Johansen, M. C., Katan, M., Murthy, S. B., Schachter, M., Sur, B., Yaghi, N., Aspberg, S., & Caso, S. (2025). Ischemic stroke prevention in patients with atrial fibrillation and a recent ischemic stroke, TIA, or intracranial hemorrhage: A World Stroke Organization (WSO) scientific statement. International Journal Of Stroke : Official Journal Of The International Stroke Society, 17474930241312649. https:\/\/doi.org\/10.1177\/17474930241312649","DOI":"10.1177\/17474930241312649"},{"key":"538_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007). Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals Of Internal Medicine, 146, 857\u2013867. https:\/\/doi.org\/10.7326\/0003-4819-146-12-200706190-00007","journal-title":"Annals Of Internal Medicine"},{"key":"538_CR6","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s00415-013-6935-x","volume":"260","author":"R Wachter","year":"2013","unstructured":"Wachter, R., Weber-Kr\u00fcger, M., Seegers, J., Edelmann, F., Wohlfahrt, J., Wasser, K., Gelbrich, G., Hasenfu\u00df, G., Stahrenberg, R., Liman, J., et al. (2013). Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study. Journal Of Neurology, 260, 2042\u20132045. https:\/\/doi.org\/10.1007\/s00415-013-6935-x","journal-title":"Journal Of Neurology"},{"key":"538_CR7","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1001\/jama.2015.4369","volume":"313","author":"GYH Lip","year":"2015","unstructured":"Lip, G. Y. H., & Lane, D. A. (2015). Stroke prevention in atrial fibrillation: a systematic review. Journal Of The American Medical Association, 313, 1950\u20131962. https:\/\/doi.org\/10.1001\/jama.2015.4369","journal-title":"Journal Of The American Medical Association"},{"key":"538_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstr\u00f6m-Lundqvist, C., Boriani, G., Castella, M., Dan, G-A., Dilaveris, P. E., et al. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal, 42, 373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"European Heart Journal"},{"key":"538_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/ane.12203","volume":"129","author":"MA Baturova","year":"2014","unstructured":"Baturova, M. A., Lindgren, A., Shubik, Y. V., Olsson, S. B., & Platonov, P. G. (2014). Documentation of atrial fibrillation prior to first-ever ischemic stroke. Acta Neurologica Scandinavica, 129, 412\u2013419. https:\/\/doi.org\/10.1111\/ane.12203","journal-title":"Acta Neurologica Scandinavica"},{"key":"538_CR10","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","volume":"27","author":"HJ Lin","year":"1996","unstructured":"Lin, H. J., Wolf, P. A., Kelly-Hayes, M., Beiser, A. S., Kase, C. S., Benjamin, E. J., & D\u2019Agostino, R. B. (1996). Stroke severity in atrial fibrillation. The Framingham Study. Stroke, 27, 1760\u20131764. https:\/\/doi.org\/10.1161\/01.STR.27.10.1760","journal-title":"Stroke"},{"key":"538_CR11","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","volume":"38","author":"IC van Gelder","year":"2017","unstructured":"van Gelder, I. C., Healey, J. S., Crijns, H. J. G. M., Wang, J., Hohnloser, S. H., Gold, M. R., Capucci, A., Lau, C-P., Morillo, C. A., Hobbelt, A. H., et al. (2017). Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. European Heart Journal, 38, 1339\u20131344. https:\/\/doi.org\/10.1093\/eurheartj\/ehx042","journal-title":"European Heart Journal"},{"key":"538_CR12","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"BF Gage","year":"2001","unstructured":"Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001). Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. Journal Of The American Medical Association, 285, 2864\u20132870. https:\/\/doi.org\/10.1001\/jama.285.22.2864","journal-title":"Journal Of The American Medical Association"},{"key":"538_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137, 263\u2013272. https:\/\/doi.org\/10.1378\/chest.09-1584","journal-title":"Chest"},{"key":"538_CR14","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC van Gelder","year":"2024","unstructured":"van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., de Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024). 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 45, 3314\u20133414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176","journal-title":"European Heart Journal"},{"key":"538_CR15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024). 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149, e1\u2013e156. https:\/\/doi.org\/10.1161\/CIR.0000000000001193","journal-title":"Circulation"},{"key":"538_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/europace\/euac062","volume":"25","author":"RB Schnabel","year":"2023","unstructured":"Schnabel, R. B., Marinelli, E. A., Arbelo, E., Boriani, G., Boveda, S., Buckley, C. M., Camm, A. J., Casadei, B., Chua, W., Dagres, N., et al. (2023). Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET\/EHRA consensus conference. Europace, 25, 6\u201327. https:\/\/doi.org\/10.1093\/europace\/euac062","journal-title":"Europace"},{"key":"538_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00415-026-13635-1","volume":"273","author":"J Zhao","year":"2026","unstructured":"Zhao, J., Chen, C., Lu, L., Wang, L., & Chen, F. (2026). NOACs effects in the secondary prevention of atrial fibrillation-related ischemic stroke\/TIA: a systematic review and meta-analysis. Journal Of Neurology, 273, 113. https:\/\/doi.org\/10.1007\/s00415-026-13635-1","journal-title":"Journal Of Neurology"},{"key":"538_CR18","doi-asserted-by":"publisher","unstructured":"Sapapsap, B., Aree, W., Ruenroengbun, N., Santimaleeworagun, W., & Boonmuang, P. (2026). Standard- Versus Reduced-Dose Apixaban and Vitamin K Antagonists in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. JCM, 15. https:\/\/doi.org\/10.3390\/jcm15124664","DOI":"10.3390\/jcm15124664"},{"key":"538_CR19","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","volume":"388","author":"U Fischer","year":"2023","unstructured":"Fischer, U., Koga, M., Strbian, D., Branca, M., Abend, S., Trelle, S., Paciaroni, M., Thomalla, G., Michel, P., Nedeltchev, K., et al. (2023). Early versus Later Anticoagulation for Stroke with Atrial Fibrillation. New England Journal Of Medicine, 388, 2411\u20132421. https:\/\/doi.org\/10.1056\/NEJMoa2303048","journal-title":"New England Journal Of Medicine"},{"key":"538_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)02197-4","author":"DJ Werring","year":"2024","unstructured":"Werring, D. J., Dehbi, H-M., Ahmed, N., Arram, L., Best, J. G., Balogun, M., Bennett, K., Bordea, E., Caverly, E., Chau, M., et al. (2024). Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial. Lancet. https:\/\/doi.org\/10.1016\/s0140-6736(24)02197-4","journal-title":"Lancet"},{"key":"538_CR21","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1177\/23969873241238508","volume":"9","author":"K Aarnio","year":"2024","unstructured":"Aarnio, K., Martinez-Majander, N., Haapaniemi, E., Kokkola, E., Broman, J., Tulkki, L., Kaste, M., Tatlisumak, T., & Putaala, J. (2024). Etiologic subtypes of first and recurrent ischemic stroke in young patients using A-S-C-O and TOAST classification criteria: A retrospective follow-up study. Eur Stroke J, 9, 1034\u20131042. https:\/\/doi.org\/10.1177\/23969873241238508","journal-title":"Eur Stroke J"},{"key":"538_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/ene.12068","volume":"20","author":"ME Wolf","year":"2013","unstructured":"Wolf, M. E., Sauer, T., Hennerici, M. G., & Chatzikonstantinou, A. (2013). Characterization of patients with recurrent ischaemic stroke using the ASCO classification. European Journal Of Neurology, 20, 812\u2013817. https:\/\/doi.org\/10.1111\/ene.12068","journal-title":"European Journal Of Neurology"},{"key":"538_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1474-4422(22)00436-7","volume":"22","author":"M Jensen","year":"2023","unstructured":"Jensen, M., Suling, A., Metzner, A., Schnabel, R. B., Borof, K., Goette, A., Haeusler, K. G., Zapf, A., Wegscheider, K., Fabritz, L., et al. (2023). Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial. Lancet Neurology, 22, 45\u201354. https:\/\/doi.org\/10.1016\/S1474-4422(22)00436-7","journal-title":"Lancet Neurology"},{"key":"538_CR24","doi-asserted-by":"publisher","first-page":"e023391","DOI":"10.1161\/JAHA.121.023391","volume":"11","author":"J Park","year":"2022","unstructured":"Park, J., Shim, J., Lee, J. M., Park, J-K., Heo, J., Chang, Y., Song, T-J., Kim, D-H., Lee, H. A., Yu, H. T., et al. (2022). Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial). J Am Heart Assoc, 11, e023391. https:\/\/doi.org\/10.1161\/JAHA.121.023391","journal-title":"J Am Heart Assoc"},{"key":"538_CR25","doi-asserted-by":"publisher","unstructured":"Jensen, M., Zapf, A., Buchholz, A., M\u00f6hl, A., Andrade, J. G., Cameron, A., Campbell, B. C. V., Fischer, U., Hill, M. D., Kelly, P., et al. (2026). Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE): protocol for an international investigator-initiated, prospective, randomised, open, blinded endpoint assessment (PROBE) interventional multi-centre trial. Eur Stroke J, 11. https:\/\/doi.org\/10.1093\/esj\/aakag022","DOI":"10.1093\/esj\/aakag022"},{"key":"538_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa2407105","volume":"392","author":"JP Piccini","year":"2025","unstructured":"Piccini, J. P., Patel, M. R., Steffel, J., Ferdinand, K., van Gelder, I. C., Russo, A. M., Ma, C-S., Goodman, S. G., Oldgren, J., Hammett, C., et al. (2025). Asundexian versus Apixaban in Patients with Atrial Fibrillation. New England Journal Of Medicine, 392, 23\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2407105","journal-title":"New England Journal Of Medicine"},{"key":"538_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1056\/NEJMoa2406674","volume":"392","author":"CT Ruff","year":"2025","unstructured":"Ruff, C. T., Patel, S. M., Giugliano, R. P., Morrow, D. A., Hug, B., Kuder, J. F., Goodrich, E. L., Chen, S-A., Goodman, S. G., Joung, B., et al. (2025). Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. New England Journal Of Medicine, 392, 361\u2013371. https:\/\/doi.org\/10.1056\/NEJMoa2406674","journal-title":"New England Journal Of Medicine"},{"key":"538_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ahj.2024.08.011","volume":"277","author":"SS Jain","year":"2024","unstructured":"Jain, S. S., Mahaffey, K. W., Pieper, K. S., Shimizu, W., Potpara, T., Ruff, C. T., Kamel, H., Lewis, B. S., Cornel, J. H., Kowey, P. R., et al. (2024). Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design. American Heart Journal, 277, 145\u2013158. https:\/\/doi.org\/10.1016\/j.ahj.2024.08.011","journal-title":"American Heart Journal"},{"key":"538_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1474-4422(24)00037-1","volume":"23","author":"DJ Seiffge","year":"2024","unstructured":"Seiffge, D. J., Cancelloni, V., R\u00e4ber, L., Paciaroni, M., Metzner, A., Kirchhof, P., Fischer, U., Werring, D. J., Shoamanesh, A., & Caso, V. (2024). Secondary stroke prevention in people with atrial fibrillation: treatments and trials. Lancet Neurology, 23, 404\u2013417. https:\/\/doi.org\/10.1016\/S1474-4422(24)00037-1","journal-title":"Lancet Neurology"},{"key":"538_CR30","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/jamaneurol.2025.1337","volume":"82","author":"JJ McCabe","year":"2025","unstructured":"McCabe, J. J., Cheung, Y., Foley, M., Brennan, S. O., Buckley, J., Renom, P. C., Cassidy, T., Collins, R., Dolan, E., Grosse, G. M., et al. (2025). Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis. JAMA Neurol, 82, 696\u2013705. https:\/\/doi.org\/10.1001\/jamaneurol.2025.1337","journal-title":"JAMA Neurol"},{"key":"538_CR31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.25700","volume":"87","author":"DJ Seiffge","year":"2020","unstructured":"Seiffge, D. J., de Marchis, G. M., Koga, M., Paciaroni, M., Wilson, D., Cappellari, M., Macha Md, K., Tsivgoulis, G., Ambler, G., Arihiro, S., et al. (2020). Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation. Annals Of Neurology, 87, 677\u2013687. https:\/\/doi.org\/10.1002\/ana.25700","journal-title":"Annals Of Neurology"},{"key":"538_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/jnnp-2021-328391","volume":"93","author":"AA Polymeris","year":"2022","unstructured":"Polymeris, A. A., Meinel, T. R., Oehler, H., H\u00f6lscher, K., Zietz, A., Scheitz, J. F., Nolte, C. H., Stretz, C., Yaghi, S., Stoll, S., et al. (2022). Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. Journal Of Neurology, Neurosurgery And Psychiatry, 93, 588\u2013598. https:\/\/doi.org\/10.1136\/jnnp-2021-328391","journal-title":"Journal Of Neurology, Neurosurgery And Psychiatry"},{"key":"538_CR33","doi-asserted-by":"publisher","first-page":"e70387","DOI":"10.1111\/ene.70387","volume":"32","author":"L Palaiodimou","year":"2025","unstructured":"Palaiodimou, L., & Tsivgoulis, G. (2025). Cardioembolic Breakthrough Stroke: When Anticoagulation Fails, Is Left Atrial Appendage Closure the Next Step? European Journal Of Neurology, 32, e70387. https:\/\/doi.org\/10.1111\/ene.70387","journal-title":"European Journal Of Neurology"},{"key":"538_CR34","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.jacep.2025.02.047","volume":"11","author":"WF McIntyre","year":"2025","unstructured":"McIntyre, W. F., Jolly, S. S., Whitlock, R. P., & Healey, J. S. (2025). Introducing the Fourth Left Atrial Appendage Occlusion Study. JACC Clin Electrophysiol, 11, 1041. https:\/\/doi.org\/10.1016\/j.jacep.2025.02.047","journal-title":"JACC Clin Electrophysiol"},{"key":"538_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ahj.2021.08.020","volume":"243","author":"K Korsholm","year":"2022","unstructured":"Korsholm, K., Damgaard, D., Valentin, J. B., Packer, E. J. S., Odenstedt, J., Sinisalo, J., Putaala, J., N\u00e6ss, H., Al-Jazi, M. A., Karlsson, J-E., et al. (2022). Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial. American Heart Journal, 243, 28\u201338. https:\/\/doi.org\/10.1016\/j.ahj.2021.08.020","journal-title":"American Heart Journal"},{"key":"538_CR36","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11886-020-01388-w","volume":"22","author":"T de Potter","year":"2020","unstructured":"de Potter, T., Yodfat, O., Shinar, G., Neta, A., Reddy, V. Y., Neuzil, P., Veltkamp, R., & Connolly, S. J. (2020). Permanent Bilateral Carotid Filters for Stroke Prevention in Atrial Fibrillation. Current Cardiology Reports, 22, 144. https:\/\/doi.org\/10.1007\/s11886-020-01388-w","journal-title":"Current Cardiology Reports"},{"key":"538_CR37","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1161\/STROKEAHA.121.034777","volume":"53","author":"LA Sposato","year":"2022","unstructured":"Sposato, L. A., Chaturvedi, S., Hsieh, C-Y., Morillo, C. A., & Kamel, H. (2022). Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views. Stroke, 53, e94\u2013e103. https:\/\/doi.org\/10.1161\/STROKEAHA.121.034777","journal-title":"Stroke"},{"key":"538_CR38","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna, T., Diener, H-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014). Cryptogenic stroke and underlying atrial fibrillation. New England Journal Of Medicine, 370, 2478\u20132486. https:\/\/doi.org\/10.1056\/NEJMoa1313600","journal-title":"New England Journal Of Medicine"},{"key":"538_CR39","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"DJ Gladstone","year":"2014","unstructured":"Gladstone, D. J., Spring, M., Dorian, P., Panzov, V., Thorpe, K. E., Hall, J., Vaid, H., O\u2019Donnell, M., Laupacis, A., C\u00f4t\u00e9, R., et al. (2014). Atrial fibrillation in patients with cryptogenic stroke. New England Journal Of Medicine, 370, 2467\u20132477. https:\/\/doi.org\/10.1056\/NEJMoa1311376","journal-title":"New England Journal Of Medicine"},{"key":"538_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5853\/jos.2021.01207","volume":"24","author":"R Wachter","year":"2022","unstructured":"Wachter, R., Weber-Kr\u00fcger, M., Hamann, G. F., Kermer, P., Liman, J., Mende, M., Seegers, J., Wasser, K., Gr\u00f6schel, S., Uphaus, T., et al. (2022). Long-Term Follow-up of Enhanced Holter-Electrocardiography Monitoring in Acute Ischemic Stroke. J Stroke, 24, 98\u2013107. https:\/\/doi.org\/10.5853\/jos.2021.01207","journal-title":"J Stroke"},{"key":"538_CR41","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1001\/jama.2021.6470","volume":"325","author":"RA Bernstein","year":"2021","unstructured":"Bernstein, R. A., Kamel, H., Granger, C. B., Piccini, J. P., Sethi, P. P., Katz, J. M., Vives, C. A., Ziegler, P. D., Franco, N. C., & Schwamm, L. H. (2021). Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial. Journal Of The American Medical Association, 325, 2169\u20132177. https:\/\/doi.org\/10.1001\/jama.2021.6470","journal-title":"Journal Of The American Medical Association"},{"key":"538_CR42","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1001\/jama.2021.6128","volume":"325","author":"BH Buck","year":"2021","unstructured":"Buck, B. H., Hill, M. D., Quinn, F. R., Butcher, K. S., Menon, B. K., Gulamhusein, S., Siddiqui, M., Coutts, S. B., Jeerakathil, T., Smith, E. E., et al. (2021). Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke: The PER DIEM Randomized Clinical Trial. Journal Of The American Medical Association, 325, 2160\u20132168. https:\/\/doi.org\/10.1001\/jama.2021.6128","journal-title":"Journal Of The American Medical Association"},{"key":"538_CR43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1474-4422(21)00067-3","volume":"20","author":"KG Haeusler","year":"2021","unstructured":"Haeusler, K. G., Kirchhof, P., Kunze, C., T\u00fct\u00fcnc\u00fc, S., Fiessler, C., Malsch, C., Olma, M. C., Jawad-Ul-Qamar, M., Kr\u00e4mer, M., Wachter, R., et al. (2021). Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study. Lancet Neurology, 20, 426\u2013436. https:\/\/doi.org\/10.1016\/S1474-4422(21)00067-3","journal-title":"Lancet Neurology"},{"key":"538_CR44","doi-asserted-by":"publisher","first-page":"e1942","DOI":"10.1212\/WNL.0000000000200227","volume":"98","author":"G Tsivgoulis","year":"2022","unstructured":"Tsivgoulis, G., Triantafyllou, S., Palaiodimou, L., Grory, B. M., Deftereos, S., K\u00f6hrmann, M., Dilaveris, P., Ricci, B., Tsioufis, K., Cutting, S., et al. (2022). Prolonged Cardiac Monitoring and Stroke Recurrence: A Meta-analysis. Neurology, 98, e1942\u2013e1952. https:\/\/doi.org\/10.1212\/WNL.0000000000200227","journal-title":"Neurology"},{"key":"538_CR45","doi-asserted-by":"publisher","first-page":"VI","DOI":"10.1177\/23969873221099478","volume":"7","author":"M Rubiera","year":"2022","unstructured":"Rubiera, M., Aires, A., Antonenko, K., L\u00e9meret, S., Nolte, C. H., Putaala, J., Schnabel, R. B., Tuladhar, A. M., Werring, D. J., Zeraatkar, D., et al. (2022). European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin. Eur Stroke J, 7, VI. https:\/\/doi.org\/10.1177\/23969873221099478","journal-title":"Eur Stroke J"},{"key":"538_CR46","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021). 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association. Stroke, 52, e364\u2013e467. https:\/\/doi.org\/10.1161\/STR.0000000000000375","journal-title":"Stroke"},{"key":"538_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s42451-022-00461-8","volume":"5","author":"GF Hamann","year":"2022","unstructured":"Hamann, G. F., Sander, D., Grau, A., & R\u00f6ther, J. (2022). S2k-Leitlinie: Sekund\u00e4rprophylaxe isch\u00e4mischer Schlaganfall und transitorische isch\u00e4mische Attacke (TIA) \u2013 Teil 1 und Teil 2. DGNeurologie, 5, 369\u2013380. https:\/\/doi.org\/10.1007\/s42451-022-00461-8","journal-title":"DGNeurologie"},{"key":"538_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1017\/cjn.2021.127","volume":"49","author":"DJ Gladstone","year":"2022","unstructured":"Gladstone, D. J., Lindsay, M. P., Douketis, J., Smith, E. E., Dowlatshahi, D., Wein, T., Bourgoin, A., Cox, J., Falconer, J. B., Graham, B. R., et al. (2022). Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020. Canadian Journal Of Neurological Sciences, 49, 315\u2013337. https:\/\/doi.org\/10.1017\/cjn.2021.127","journal-title":"Canadian Journal Of Neurological Sciences"},{"key":"538_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24050","volume":"24","author":"SJ Edwards","year":"2020","unstructured":"Edwards, S. J., Wakefield, V., Jhita, T., Kew, K., Cain, P., & Marceniuk, G. (2020). Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation. Health Technology Assessment, 24, 1\u2013184. https:\/\/doi.org\/10.3310\/hta24050","journal-title":"Health Technology Assessment"},{"key":"538_CR50","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000520101","volume":"51","author":"S Fridman","year":"2022","unstructured":"Fridman, S., Jimenez-Ruiz, A., Vargas-Gonzalez, J. C., & Sposato, L. A. (2022). Differences between Atrial Fibrillation Detected before and after Stroke and TIA: A Systematic Review and Meta-Analysis. Cerebrovascular Diseases (Basel, Switzerland), 51, 152\u2013157. https:\/\/doi.org\/10.1159\/000520101","journal-title":"Cerebrovascular Diseases (Basel, Switzerland)"},{"key":"538_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(23)00326-5","volume":"23","author":"LA Sposato","year":"2024","unstructured":"Sposato, L. A., Field, T. S., Schnabel, R. B., Wachter, R., Andrade, J. G., & Hill, M. D. (2024). Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack. Lancet Neurology, 23, 110\u2013122. https:\/\/doi.org\/10.1016\/S1474-4422(23)00326-5","journal-title":"Lancet Neurology"},{"key":"538_CR52","doi-asserted-by":"publisher","unstructured":"Ababneh, G. E., Yassin, A., Allahham, M., Alawneh, K., Hamed, S., Alomari, S. A., Jaradat, M. B., Alkhawaldeh, A., & Almbaidin, A. (2025). Prevalence and predictors of atrial fibrillation detected after stroke or transient ischemic attack: A comprehensive meta-analysis. International Journal Of Stroke : Official Journal Of The International Stroke Society, 17474930251398615. https:\/\/doi.org\/10.1177\/17474930251398615","DOI":"10.1177\/17474930251398615"},{"key":"538_CR53","doi-asserted-by":"publisher","first-page":"e003333","DOI":"10.1161\/CIRCEP.115.003333","volume":"9","author":"J Brachmann","year":"2016","unstructured":"Brachmann, J., Morillo, C. A., Sanna, T., Di Lazzaro, V., Diener, H-C., Bernstein, R. A., Rymer, M., Ziegler, P. D., Liu, S., & Passman, R. S. (2016). Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial. Circ Arrhythm Electrophysiol, 9, e003333. https:\/\/doi.org\/10.1161\/CIRCEP.115.003333","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"538_CR54","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/ene.14061","volume":"27","author":"E Cuadrado-Godia","year":"2020","unstructured":"Cuadrado-Godia, E., Benito, B., Ois, A., Vall\u00e8s, E., Rodr\u00edguez-Campello, A., Giralt-Steinhauer, E., Cabrera, S., Alcalde, O., Jim\u00e9nez-L\u00f3pez, J., Jim\u00e9nez-Conde, J., et al. (2020). Ultra-early continuous cardiac monitoring improves atrial fibrillation detection and prognosis of patients with cryptogenic stroke. European Journal Of Neurology, 27, 244\u2013250. https:\/\/doi.org\/10.1111\/ene.14061","journal-title":"European Journal Of Neurology"},{"key":"538_CR55","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ana.25886","volume":"88","author":"S Triantafyllou","year":"2020","unstructured":"Triantafyllou, S., Katsanos, A. H., Dilaveris, P., Giannopoulos, G., Kossyvakis, C., Adreanides, E., Liantinioti, C., Tympas, K., Zompola, C., Theodorou, A., et al. (2020). Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic Stroke. Annals Of Neurology, 88, 946\u2013955. https:\/\/doi.org\/10.1002\/ana.25886","journal-title":"Annals Of Neurology"},{"key":"538_CR56","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.01.028","volume":"27","author":"B Ricci","year":"2018","unstructured":"Ricci, B., Chang, A. D., Hemendinger, M., Dakay, K., Cutting, S., Burton, T., Mac Grory, B., Narwal, P., Song, C., Chu, A., et al. (2018). A Simple Score That Predicts Paroxysmal Atrial Fibrillation on Outpatient Cardiac Monitoring after Embolic Stroke of Unknown Source. Journal Of Stroke And Cerebrovascular Diseases : The Official Journal Of National Stroke Association, 27, 1692\u20131696. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.01.028","journal-title":"Journal Of Stroke And Cerebrovascular Diseases : The Official Journal Of National Stroke Association"},{"key":"538_CR57","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ahj.2023.06.016","volume":"265","author":"T Uhe","year":"2023","unstructured":"Uhe, T., Wasser, K., Weber-Kr\u00fcger, M., Sch\u00e4bitz, W-R., K\u00f6hrmann, M., Brachmann, J., Laufs, U., Dichgans, M., Gelbrich, G., Petroff, D., et al. (2023). Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism-the Find-AF 2 study-rationale and design. American Heart Journal, 265, 66\u201376. https:\/\/doi.org\/10.1016\/j.ahj.2023.06.016","journal-title":"American Heart Journal"},{"key":"538_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s42466-025-00399-8","volume":"7","author":"K Wasser","year":"2025","unstructured":"Wasser, K., Uhe, T., Sch\u00e4bitz, W-R., K\u00f6hrmann, M., Dichgans, M., Brachmann, J., Laufs, U., Gelbrich, G., Petroff, D., Prettin, C., et al. (2025). Baseline characteristics of patients with acute ischaemic stroke included in the randomised controlled Find-AF 2 trial. Neurol Res Pract, 7, 45. https:\/\/doi.org\/10.1186\/s42466-025-00399-8","journal-title":"Neurol Res Pract"},{"key":"538_CR59","doi-asserted-by":"publisher","first-page":"e073470","DOI":"10.1136\/bmjopen-2023-073470","volume":"13","author":"J Engdahl","year":"2023","unstructured":"Engdahl, J., Straat, K., Isaksson, E., Rooth, E., Svennberg, E., Norrving, B., von Euler, M., Hellqvist, K., Gu, W., Str\u00f6m, J. O., et al. (2023). Multicentre, national, investigator-initiated, randomised, parallel-group, register-based superiority trial to compare extended ECG monitoring versus standard ECG monitoring in elderly patients with ischaemic stroke or transient ischaemic attack and the effect on stroke, death and intracerebral bleeding: the AF SPICE protocol. British Medical Journal Open, 13, e073470. https:\/\/doi.org\/10.1136\/bmjopen-2023-073470","journal-title":"British Medical Journal Open"},{"key":"538_CR60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012). Subclinical atrial fibrillation and the risk of stroke. New England Journal Of Medicine, 366, 120\u2013129. https:\/\/doi.org\/10.1056\/NEJMoa1105575","journal-title":"New England Journal Of Medicine"},{"key":"538_CR61","doi-asserted-by":"publisher","first-page":"e944","DOI":"10.1161\/CIR.0000000000000740","volume":"140","author":"PA Noseworthy","year":"2019","unstructured":"Noseworthy, P. A., Kaufman, E. S., Chen, L. Y., Chung, M. K., Elkind, M. S. V., Joglar, J. A., Leal, M. A., McCabe, P. J., Pokorney, S. D., & Yao, X. (2019). Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. Circulation, 140, e944\u2013e963. https:\/\/doi.org\/10.1161\/CIR.0000000000000740","journal-title":"Circulation"},{"key":"538_CR62","doi-asserted-by":"publisher","first-page":"e035956","DOI":"10.1161\/JAHA.124.035956","volume":"13","author":"K Toyoda","year":"2024","unstructured":"Toyoda, K., Kusano, K., Iguchi, Y., Ikeda, T., Morishima, I., Tomita, H., Asano, T., Yamane, T., Nakahara, I., Watanabe, E., et al. (2024). Global Results of Implantable Loop Recorder for Detection of Atrial Fibrillation After Stroke: Reveal LINQ Registry. J Am Heart Assoc, 13, e035956. https:\/\/doi.org\/10.1161\/JAHA.124.035956","journal-title":"J Am Heart Assoc"},{"key":"538_CR63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2310234","volume":"390","author":"JS Healey","year":"2024","unstructured":"Healey, J. S., Lopes, R. D., Granger, C. B., Alings, M., Rivard, L., McIntyre, W. F., Atar, D., Birnie, D. H., Boriani, G., Camm, A. J., et al. (2024). Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. New England Journal Of Medicine, 390, 107\u2013117. https:\/\/doi.org\/10.1056\/NEJMoa2310234","journal-title":"New England Journal Of Medicine"},{"key":"538_CR64","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","volume":"389","author":"P Kirchhof","year":"2023","unstructured":"Kirchhof, P., Toennis, T., Goette, A., Camm, A. J., Diener, H. C., Becher, N., Bertaglia, E., Blomstrom Lundqvist, C., Borlich, M., Brandes, A., et al. (2023). Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. New England Journal Of Medicine, 389, 1167\u20131179. https:\/\/doi.org\/10.1056\/NEJMoa2303062","journal-title":"New England Journal Of Medicine"},{"key":"538_CR65","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","volume":"149","author":"WF McIntyre","year":"2024","unstructured":"McIntyre, W. F., Benz, A. P., Becher, N., Healey, J. S., Granger, C. B., Rivard, L., Camm, A. J., Goette, A., Zapf, A., Alings, M., et al. (2024). Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials. Circulation, 149, 981\u2013988. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067512","journal-title":"Circulation"},{"key":"538_CR66","doi-asserted-by":"publisher","unstructured":"Palaiodimou, L., Katsanos, A. H., Melanis, K., Stefanou, M-I., Romoli, M., Papagiannopoulou, G., Theodorou, A., K\u00f6hrmann, M., Dilaveris, P., Tsioufis, K., et al. (2025). Recurrent stroke in patients with history of stroke\/transient ischemic attack and device-detected atrial fibrillation: A systematic review and meta-analysis. Eur Stroke J, 23969873251334278. https:\/\/doi.org\/10.1177\/23969873251334278","DOI":"10.1177\/23969873251334278"},{"key":"538_CR67","doi-asserted-by":"publisher","first-page":"e70251","DOI":"10.1111\/ene.70251","volume":"32","author":"L Pantoni","year":"2025","unstructured":"Pantoni, L., Mele, F., Pescini, F., Rafanelli, M., Zivelonghi, C., Tomasi, L., Mugnai, G., Tomaselli, C., Petrone, A., Adami, A., et al. (2025). Long-Term Detection of Subclinical Atrial Fibrillation in Cryptogenic Stroke Patients With Insertable Cardiac Monitors. European Journal Of Neurology, 32, e70251. https:\/\/doi.org\/10.1111\/ene.70251","journal-title":"European Journal Of Neurology"},{"key":"538_CR68","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(24)00475-7","volume":"24","author":"A Shoamanesh","year":"2025","unstructured":"Shoamanesh, A., Field, T. S., Coutts, S. B., Sharma, M., Gladstone, D., Hart, R. G., Boriani, G., Wright, D. J., Sticherling, C., Birnie, D. H., et al. (2025). Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial. Lancet Neurology, 24, 140\u2013151. https:\/\/doi.org\/10.1016\/S1474-4422(24)00475-7","journal-title":"Lancet Neurology"},{"key":"538_CR69","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010). A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest, 138, 1093\u20131100. https:\/\/doi.org\/10.1378\/chest.10-0134","journal-title":"Chest"},{"key":"538_CR70","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1055\/s-0041-1726403","volume":"121","author":"R Wachter","year":"2021","unstructured":"Wachter, R., & Freedman, B. (2021). Subclinical Atrial Fibrillation and the Risk of Recurrent Ischemic Stroke. Thrombosis And Haemostasis, 121, 697\u2013699. https:\/\/doi.org\/10.1055\/s-0041-1726403","journal-title":"Thrombosis And Haemostasis"},{"key":"538_CR71","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.3390\/jcm14155222","volume":"14","author":"B Alhwarat","year":"2025","unstructured":"Alhwarat, B., Darwish, O., Ghanta, S. N., Rana, A., Gautam, N., Al\u2019Aref, S. J., & Devabhaktuni, S. (2025). Contemporary Practices for Management of Subclinical Atrial Fibrillation. JCM, 14, 5222. https:\/\/doi.org\/10.3390\/jcm14155222","journal-title":"JCM"},{"key":"538_CR72","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMra2411298","volume":"394","author":"SM Greenberg","year":"2026","unstructured":"Greenberg, S. M. (2026). Cerebral Amyloid Angiopathy. New England Journal Of Medicine, 394, 1836\u20131845. https:\/\/doi.org\/10.1056\/NEJMra2411298","journal-title":"New England Journal Of Medicine"},{"key":"538_CR73","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1161\/STROKEAHA.124.044293","volume":"55","author":"SM Greenberg","year":"2024","unstructured":"Greenberg, S. M., & van Veluw, S. J. (2024). Cerebral Amyloid Angiopathy. Stroke, 55, 1409\u20131411. https:\/\/doi.org\/10.1161\/STROKEAHA.124.044293","journal-title":"Stroke"},{"key":"538_CR74","first-page":"316","volume":"28","author":"EM Haacke","year":"2007","unstructured":"Haacke, E. M., DelProposto, Z. S., Chaturvedi, S., Sehgal, V., Tenzer, M., Neelavalli, J., & Kido, D. (2007). Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. Ajnr. American Journal Of Neuroradiology, 28, 316\u2013317.","journal-title":"Ajnr. American Journal Of Neuroradiology"},{"key":"538_CR75","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"Charidimou, A., Boulouis, G., Frosch, M. P., Baron, J-C., Pasi, M., Albucher, J. F., Banerjee, G., Barbato, C., Bonneville, F., Brandner, S., et al. (2022). The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurology, 21, 714\u2013725. https:\/\/doi.org\/10.1016\/S1474-4422(22)00208-3","journal-title":"Lancet Neurology"},{"key":"538_CR76","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11886-018-1052-1","volume":"20","author":"RJ Cannistraro","year":"2018","unstructured":"Cannistraro, R. J., & Meschia, J. F. (2018). The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation. Current Cardiology Reports, 20, 106. https:\/\/doi.org\/10.1007\/s11886-018-1052-1","journal-title":"Current Cardiology Reports"},{"key":"538_CR77","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0735-1097(99)00489-1","volume":"35","author":"RG Hart","year":"2000","unstructured":"Hart, R. G., Pearce, L. A., Rothbart, R. M., McAnulty, J. H., Asinger, R. W., & Halperin, J. L. (2000). Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. Journal Of The American College Of Cardiology, 35, 183\u2013187. https:\/\/doi.org\/10.1016\/s0735-1097(99)00489-1","journal-title":"Journal Of The American College Of Cardiology"},{"key":"538_CR78","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1016\/j.mayocp.2020.03.034","volume":"95","author":"R Ward","year":"2020","unstructured":"Ward, R., Ponamgi, S., DeSimone, C. V., English, S., Hodge, D. O., Slusser, J. P., Graff-Radford, J., Rabinstein, A. A., Asirvatham, S. J., Holmes, D., & JR. (2020). Utility of HAS-BLED and CHA(2)DS(2)-VASc Scores Among Patients With Atrial Fibrillation and Imaging Evidence of Cerebral Amyloid Angiopathy. Mayo Clinic Proceedings, 95, 2090\u20132098. https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.034","journal-title":"Mayo Clinic Proceedings"},{"key":"538_CR79","doi-asserted-by":"publisher","unstructured":"Chen, H., Kakadiya, J., Salim, H. A., Essibayi, M. A., Adcock, A., Yedavalli, V. S., Dmytriw, A. A., Colasurdo, M., Malhotra, A., Gandhi, D., et al. (2026). Safety and efficacy of anticoagulation for cerebral amyloid angiopathy patients with high-risk atrial fibrillation. Journal Of Neurology, 273. https:\/\/doi.org\/10.1007\/s00415-026-13798-x","DOI":"10.1007\/s00415-026-13798-x"},{"key":"538_CR80","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1212\/WNL.0000000000004259","volume":"89","author":"A Charidimou","year":"2017","unstructured":"Charidimou, A., Imaizumi, T., Moulin, S., Biffi, A., Samarasekera, N., Yakushiji, Y., Peeters, A., Vandermeeren, Y., Laloux, P., Baron, J-C., et al. (2017). Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis. Neurology, 89, 820\u2013829. https:\/\/doi.org\/10.1212\/WNL.0000000000004259","journal-title":"Neurology"},{"key":"538_CR81","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni, L. (2010). Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurology, 9, 689\u2013701. https:\/\/doi.org\/10.1016\/S1474-4422(10)70104-6","journal-title":"Lancet Neurology"},{"key":"538_CR82","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00115-021-01206-w","volume":"93","author":"R Hau\u00dfmann","year":"2022","unstructured":"Hau\u00dfmann, R., Homeyer, P., Hau\u00dfmann, M., Brandt, M., Donix, M., Puetz, V., & Linn, J. (2022). Intrazerebrale Blutungen unter Pl\u00e4ttchenaggregationshemmung und oraler Antikoagulation bei Patienten mit zerebraler Amyloidangiopathie. Der Nervenarzt, 93, 599\u2013604. https:\/\/doi.org\/10.1007\/s00115-021-01206-w","journal-title":"Der Nervenarzt"},{"key":"538_CR83","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa2517213","volume":"394","author":"SK Doshi","year":"2026","unstructured":"Doshi, S. K., Kar, S., Nair, D. G., Waggoner, T., Agarwal, H., Moussavian, M., Kashani, A., Oza, S., Feldman, L., Sadhu, A., et al. (2026). Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation. New England Journal Of Medicine, 394, 2083\u20132094. https:\/\/doi.org\/10.1056\/NEJMoa2517213","journal-title":"New England Journal Of Medicine"},{"key":"538_CR84","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","volume":"392","author":"OM Wazni","year":"2025","unstructured":"Wazni, O. M., Saliba, W. I., Nair, D. G., Marijon, E., Schmidt, B., Hounshell, T., Ebelt, H., Skurk, C., Oza, S., Patel, C., et al. (2025). Left Atrial Appendage Closure after Ablation for Atrial Fibrillation. New England Journal Of Medicine, 392, 1277\u20131287. https:\/\/doi.org\/10.1056\/NEJMoa2408308","journal-title":"New England Journal Of Medicine"},{"key":"538_CR85","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1056\/NEJMoa2513310","volume":"394","author":"U Landmesser","year":"2026","unstructured":"Landmesser, U., Skurk, C., Kirchhof, P., Lewalter, T., Hartung, J., Rroku, A., Pieske, B., Brachmann, J., Akin, I., Jacobshagen, C., et al. (2026). Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation. New England Journal Of Medicine, 394, 1270\u20131280. https:\/\/doi.org\/10.1056\/NEJMoa2513310","journal-title":"New England Journal Of Medicine"},{"key":"538_CR86","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12975-020-00838-5","volume":"12","author":"M Schrag","year":"2021","unstructured":"Schrag, M., Mac Grory, B., Nackenoff, A., Eaton, J., Mistry, E., Kirshner, H., Yaghi, S., & Ellis, C. R. (2021). Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort. Transl Stroke Res, 12, 259\u2013265. https:\/\/doi.org\/10.1007\/s12975-020-00838-5","journal-title":"Transl Stroke Res"},{"key":"538_CR87","doi-asserted-by":"publisher","first-page":"e792","DOI":"10.1161\/STROKEAHA.121.037248","volume":"52","author":"C Blanc","year":"2021","unstructured":"Blanc, C., Blanc, G., Boveda, S., Calvi\u00e8re, L., Combes, N., Viguier, A., Mondoly, P., Albucher, J-F., Gollion, C., Fabry, V., et al. (2021). Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Coexisting Cerebral Amyloid Angiopathy. Stroke, 52, e792\u2013e793. https:\/\/doi.org\/10.1161\/STROKEAHA.121.037248","journal-title":"Stroke"},{"key":"538_CR88","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/jnnp-2024-334718","volume":"96","author":"K Thiankhaw","year":"2025","unstructured":"Thiankhaw, K., Best, J., Srivastava, S., Prachee, I., Agarwal, S., Tan, S., Calvert, P. A., Chughtai, A., Ang, R., Segal, O. R., et al. (2025). Left atrial appendage occlusion in patients with atrial fibrillation and intracerebral haemorrhage associated with cerebral amyloid angiopathy: a multicentre observational study and pooled analysis of published studies. Journal Of Neurology, Neurosurgery And Psychiatry, 96, 528\u2013536. https:\/\/doi.org\/10.1136\/jnnp-2024-334718","journal-title":"Journal Of Neurology, Neurosurgery And Psychiatry"},{"key":"538_CR89","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/1747493020974464","volume":"16","author":"MG Kozberg","year":"2021","unstructured":"Kozberg, M. G., Perosa, V., Gurol, M. E., & van Veluw, S. J. (2021). A practical approach to the management of cerebral amyloid angiopathy. International Journal Of Stroke : Official Journal Of The International Stroke Society, 16, 356\u2013369. https:\/\/doi.org\/10.1177\/1747493020974464","journal-title":"International Journal Of Stroke : Official Journal Of The International Stroke Society"},{"key":"538_CR90","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","volume":"23","author":"Global","year":"2024","unstructured":"Global (2024). regional, and national burden of stroke and its risk factors, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurology, 23, 973\u20131003. https:\/\/doi.org\/10.1016\/S1474-4422(24)00369-7","journal-title":"Lancet Neurology"},{"key":"538_CR91","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","volume":"9","author":"CJ van Asch","year":"2010","unstructured":"van Asch, C. J., Luitse, M. J., Rinkel, G. J., van der Tweel, I., Algra, A., & Klijn, C. J. (2010). Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurology, 9, 167\u2013176. https:\/\/doi.org\/10.1016\/S1474-4422(09)70340-0","journal-title":"Lancet Neurology"},{"key":"538_CR92","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/S1474-4422(23)00315-0","volume":"22","author":"R Al-Shahi Salman","year":"2023","unstructured":"Al-Shahi Salman, R., Stephen, J., Tierney, J. F., Lewis, S. C., Newby, D. E., Parry-Jones, A. R., White, P. M., Connolly, S. J., Benavente, O. R., Dowlatshahi, D., et al. (2023). Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials. Lancet Neurology, 22, 1140\u20131149. https:\/\/doi.org\/10.1016\/S1474-4422(23)00315-0","journal-title":"Lancet Neurology"},{"key":"538_CR93","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1212\/CPJ.0000000000000425","volume":"8","author":"MA Hawkes","year":"2018","unstructured":"Hawkes, M. A., & Rabinstein, A. A. (2018). Anticoagulation for atrial fibrillation after intracranial hemorrhage: A systematic review. Neurol Clin Pract, 8, 48\u201357. https:\/\/doi.org\/10.1212\/CPJ.0000000000000425","journal-title":"Neurol Clin Pract"},{"key":"538_CR94","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/jnnp-2013-306476","volume":"85","author":"MTC Poon","year":"2014","unstructured":"Poon, M. T. C., Fonville, A. F., & Al-Shahi Salman, R. (2014). Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. Journal Of Neurology, Neurosurgery And Psychiatry, 85, 660\u2013667. https:\/\/doi.org\/10.1136\/jnnp-2013-306476","journal-title":"Journal Of Neurology, Neurosurgery And Psychiatry"},{"key":"538_CR95","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1212\/01.wnl.0000250340.05202.8b","volume":"68","author":"ML Flaherty","year":"2007","unstructured":"Flaherty, M. L., Kissela, B., Woo, D., Kleindorfer, D., Alwell, K., Sekar, P., Moomaw, C. J., Haverbusch, M., & Broderick, J. P. (2007). The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology, 68, 116\u2013121. https:\/\/doi.org\/10.1212\/01.wnl.0000250340.05202.8b","journal-title":"Neurology"},{"key":"538_CR96","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/STROKEAHA.118.024449","volume":"50","author":"B Casolla","year":"2019","unstructured":"Casolla, B., Moulin, S., Kyheng, M., H\u00e9non, H., Labreuche, J., Leys, D., Bauters, C., & Cordonnier, C. (2019). Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke, 50, 1100\u20131107. https:\/\/doi.org\/10.1161\/STROKEAHA.118.024449","journal-title":"Stroke"},{"key":"538_CR97","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1474-4422(21)00075-2","volume":"20","author":"L Li","year":"2021","unstructured":"Li, L., Poon, M. T. C., Samarasekera, N. E., Perry, L. A., Moullaali, T. J., Rodrigues, M. A., Loan, J. J. M., Stephen, J., Lerpiniere, C., Tuna, M. A., et al. (2021). Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies. Lancet Neurology, 20, 437\u2013447. https:\/\/doi.org\/10.1016\/S1474-4422(21)00075-2","journal-title":"Lancet Neurology"},{"key":"538_CR98","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7","volume":"20","author":"SoSTART Collaboration","year":"2021","unstructured":"SoSTART Collaboration. (2021). Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial. Lancet Neurology, 20, 842\u2013853. https:\/\/doi.org\/10.1016\/S1474-4422(21)00264-7","journal-title":"Lancet Neurology"},{"key":"538_CR99","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","volume":"20","author":"FHBM Schreuder","year":"2021","unstructured":"Schreuder, F. H. B. M., van Nieuwenhuizen, K. M., Hofmeijer, J., Vermeer, S. E., Kerkhoff, H., Zock, E., Luijckx, G-J., Messchendorp, G. P., van Tuijl, J., Bienfait, H. P., et al. (2021). Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial. Lancet Neurology, 20, 907\u2013916. https:\/\/doi.org\/10.1016\/S1474-4422(21)00298-2","journal-title":"Lancet Neurology"},{"key":"538_CR100","unstructured":"Shoamanesh, A., Sharma, M., Dowlatshahi, D. (2020). Non-vitamin K oral anticoagulants in intracerebral hemorrhage survivors with atrial Non-vitamin K oral anticoagulants in intracerebral hemorrhage survivors with atrial fibrillation: primary results of the NASPAF-ICH randomized trial. International stroke conference, : abstr LB13. 2020."},{"key":"538_CR101","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","volume":"405","author":"R Veltkamp","year":"2025","unstructured":"Veltkamp, R., Korompoki, E., Harvey, K. H., Harvey, E. R., Fie\u00dfler, C., Malzahn, U., R\u00fccker, V., Montaner, J., Caso, V., Sibon, I., et al. (2025). Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial. Lancet, 405, 927\u2013936. https:\/\/doi.org\/10.1016\/S0140-6736(25)00333-2","journal-title":"Lancet"},{"key":"538_CR102","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000001213","author":"M Jha","year":"2026","unstructured":"Jha, M., Chahodiya, D., Thaker, L., Matawala, K., Siddiqui, S., Jain, H., Maheta, D., Agrawal, S. P., Siddiq, S., Frishman, W. H., et al. (2026). Oral Anticoagulation Versus No Anticoagulation in Patients of Atrial Fibrillation With Prior History of Intracranial Hemorrhage: A Meta-Analysis. Cardiology In Review. https:\/\/doi.org\/10.1097\/CRD.0000000000001213","journal-title":"Cardiology In Review"},{"key":"538_CR103","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.hrthm.2025.06.023","volume":"22","author":"W Kaisaier","year":"2025","unstructured":"Kaisaier, W., Guan, C., Ye, M., Guo, S., Chen, Y., Dong, Y., Lip, G. Y. H., Liu, C., & Zhu, W. (2025). Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage. Heart Rhythm : The Official Journal Of The Heart Rhythm Society, 22, 2836\u20132844. https:\/\/doi.org\/10.1016\/j.hrthm.2025.06.023","journal-title":"Heart Rhythm : The Official Journal Of The Heart Rhythm Society"},{"key":"538_CR104","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/jnnp-2025-336169","volume":"96","author":"L D\u2019Anna","year":"2025","unstructured":"D\u2019Anna, L., Bax, F., Abu-Rumeileh, S., Barba, L., Ornello, R., Valente, M., Gigli, G. L., Sacco, S., Merlino, G., & Foschi, M. (2025). Oral anticoagulation versus no anticoagulation for stroke prevention in patients with intracranial haemorrhage and atrial fibrillation: an updated meta-analysis of randomised controlled trials. Journal Of Neurology, Neurosurgery And Psychiatry, 96, 919\u2013927. https:\/\/doi.org\/10.1136\/jnnp-2025-336169","journal-title":"Journal Of Neurology, Neurosurgery And Psychiatry"},{"key":"538_CR105","doi-asserted-by":"publisher","first-page":"109418","DOI":"10.1016\/j.thromres.2025.109418","volume":"253","author":"M Ibrahim","year":"2025","unstructured":"Ibrahim, M., Abdullah, H., Zafar, A., Kumar, A., Ajmal, F., Talib, D., Shabbir, H., Shah, M., Sardar, M., Masaud, S., et al. (2025). Efficacy and safety of direct oral anticoagulants compared to no anticoagulation for stroke prevention in atrial fibrillation patients with prior intracranial hemorrhage: A systematic review and meta-analysis. Thrombosis Research, 253, 109418. https:\/\/doi.org\/10.1016\/j.thromres.2025.109418","journal-title":"Thrombosis Research"},{"key":"538_CR106","doi-asserted-by":"publisher","first-page":"1570809","DOI":"10.3389\/fmed.2025.1570809","volume":"12","author":"D Sablot","year":"2025","unstructured":"Sablot, D., Gaillard, N., Belahsen, F., Lamelo, S. R., Dumitrana, A., Plantard, C., Daghmouri, M. A., & Chaouch, M. A. (2025). Direct oral anticoagulation versus no therapy or antiplatelet for stroke prevention in patients with atrial fibrillation and history of intracranial hemorrhage: a systematic review and meta-analysis. Front Med (Lausanne), 12, 1570809. https:\/\/doi.org\/10.3389\/fmed.2025.1570809","journal-title":"Front Med (Lausanne)"},{"key":"538_CR107","doi-asserted-by":"publisher","first-page":"e214386","DOI":"10.1212\/WNL.0000000000214386","volume":"105","author":"S Fandler-H\u00f6fler","year":"2025","unstructured":"Fandler-H\u00f6fler, S., Ropele, S., Gattringer, T., Haidegger, M., Pinter, D., Kneihsl, M., Korompoki, E., Montaner, J., Caso, V., Ringleb, P. A., et al. (2025). Neuroimaging Markers Associated With Recurrent Stroke in Intracerebral Hemorrhage and Atrial Fibrillation: Secondary Analysis of PRESTIGE-AF. Neurology, 105, e214386. https:\/\/doi.org\/10.1212\/WNL.0000000000214386","journal-title":"Neurology"},{"key":"538_CR108","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cjco.2023.03.004","volume":"5","author":"TS Gilhofer","year":"2023","unstructured":"Gilhofer, T. S., Nestelberger, T., Kang, M., Inohara, T., Alfadhel, M., McAlister, C., Reddavid, C., Samuel, R., Field, T., Teal, P., et al. (2023). Stroke Prevention With Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Prior Intracranial Hemorrhage. CJC Open, 5, 404\u2013411. https:\/\/doi.org\/10.1016\/j.cjco.2023.03.004","journal-title":"CJC Open"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-026-00538-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:13:10Z","timestamp":1792419190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-026-00538-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1186\/s42466-026-00538-9","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"5 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"85"}}